LBF-funded research

Funding research into leukaemia, lymphoma, myeloma and related blood conditions is an important strand of the LBF's work.

To date we have provided more than $1.5 million to projects and look forward to funding many more in the future.

Below are listed some of the projects we provided money for in 2004, 2005, 2006 and 2007.

2007

Associate Professor Christine Morris, So Young Moon & Dr Peter Ganly: $34,085.00 - FISH validation of novel genomic copy number variations associated with CLL identified by array of CGH
 
Associate Professor Christine Morris, Dr Sheryl Gough, Dr Tracy Hale & Dr Peter Ganly: $22,558.00 - Characterisation of genes newly implicated in acute lymphoblastic leukaemia

2006

Dr Peter Browett - $21,977.00: Inhibition of the phosphoinositide 3-kinase pathway in acute myeloid leukaemia

Dr Ian Morison & Dr Elizabeth Ledgerwood - $38,000.00: A study of New Zealand familial thrombocytopenia 

2005

Dr Judith McKenzie - $25,050.00: Are naturally occurring soluble CD40 and CD83 functional?

Dr Paul Harper - $13,905.00: Protein Z dependent protease inhibitor (ZPI) mutations in thrombosis patients 

2004

Dr Peter Browett - $6,056.74: The effect of imatinib mesylate (Gilvec TM) on bone metabolism in vitro and in vivo

Dr Sheryl Gough - $21,436.00: Novel Breakpoints & leukaemia genes, and their clinical prevalence